Trial Profile
Non-randomized, open, uncontrolled, dose comparison study of E7070 [indisulam] in patients with gastric cancer.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Indisulam (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Eisai Co Ltd
- 24 Dec 2005 New trial record.